Cyclacel Pharmaceuticals (NASDAQ:CYCC) reported quarterly losses of $(0.54) per share which beat the analyst consensus estimate of $(0.65) by 16.92 percent. This is a 14.89 percent decrease over losses of $(0.47) per share from the same period last year.
Booking Holdings Q2 EPS $(2.55) Misses $(2.10) Estimate, Sales $2.16B Beat $1.90B Estimate
Booking Holdings (NASDAQ:BKNG) reported quarterly losses of $(2.55) per share which missed the analyst consensus estimate of $(2.10) by 21.43 percent. This is a 76.41 percent increase over losses of $(10.81) per share
